about
Mast cells in gastrointestinal diseaseMastocytosis.Mastocytosis: state of the art.Systemic mastocytosis associated with splenic marginal zone lymphoma with villous lymphocytes.Mastocytosis: pathology, genetics, and current options for therapy.Systemic mastocytosis: bone marrow pathology, classification, and current therapies.Evidence for the Role of Mast Cells in Cystitis-Associated Lower Urinary Tract Dysfunction: A Multidisciplinary Approach to the Study of Chronic Pelvic Pain Research Network Animal Model Study.Mast cells and mastocytosis.Diagnosis and treatment of cutaneous mastocytosis in children: practical recommendations.Advances and controversies in the diagnosis, pathogenesis, and treatment of systemic mastocytosis.Mastocytosis: update on pharmacotherapy and future directions.Mastocytosis: the puzzling clinical spectrum and challenging diagnostic aspects of an enigmatic disease.Esophageal hypersensitivity in noncardiac chest pain.Current concepts on diagnosis and treatment of mastocytosis.Induction of apoptosis in the human mast cell leukemia cell line HMC-1 by various antineoplastic drugs.Regulation of normal and neoplastic human mast cell development in mastocytosis.Cholestatic jaundice and bone lesions in an elderly woman.Fatal bleeding due to a heparin-like anticoagulant in a 37-year-old woman suffering from systemic mastocytosis.The Study of Pyridazine Compounds on Prostanoids: Inhibitors of COX, cAMP Phosphodiesterase, and TXA2Synthase
P2860
Q24630657-38C33BF2-02B9-4BAB-AFE9-98D804C07D73Q33163541-BD8CBD3D-8473-41C1-ADEE-497E90B555B7Q34641105-A2C720F4-C61B-4FBD-A39B-C67D07733861Q35110014-F6ED4612-A21C-4950-927F-447925A58227Q35994902-019360DE-C973-4A61-B222-0887A0250A37Q36182749-3887C213-5C96-41BC-B4E0-83918B1ED6CAQ36230460-BDEA6DB7-FD7A-4D85-841C-44657B6C0BE8Q36835143-2EB5FF77-54B8-4BE9-8CA6-2FEC2D46B253Q37888657-531F60DA-36B3-49E5-AA87-245EAAC61BC8Q37892475-B6F3EFDA-3CDE-4FFD-B2A3-D8840D9AB5DAQ38138597-8EB843F4-8354-4F3D-95FD-5251D86DA557Q38582624-CFC06D12-F8B8-4FAF-B481-1E8BDAF89910Q38920063-25BF35AB-EB63-49B8-ABE7-BC404C5688F8Q38978981-8B79DC89-10A6-4AD1-A3B0-975FD76ECBBFQ40656483-BA4E6524-933A-4C44-850C-FECA558C202BQ42422156-A618AC62-3E98-478A-B80D-4472EF96F8EFQ46787106-FCC09089-4BDE-44FC-A55C-E758A8656FF4Q51722099-7E4855A4-F425-4621-BD44-E9DBBA8684C4Q59054771-EB7D7A0E-D799-48D5-82AC-1693BB666DAE
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Treatment of systemic mast cell disorders.
@ast
Treatment of systemic mast cell disorders.
@en
type
label
Treatment of systemic mast cell disorders.
@ast
Treatment of systemic mast cell disorders.
@en
prefLabel
Treatment of systemic mast cell disorders.
@ast
Treatment of systemic mast cell disorders.
@en
P1476
Treatment of systemic mast cell disorders.
@en
P2093
A S Worobec
P304
659-87, vii
P356
10.1016/S0889-8588(05)70301-4
P577
2000-06-01T00:00:00Z